DIC2-14-08 - A Phase IIA, Open-label, Safety and Pharmacokinetic Study of Zorvolex® Capsules in Pediatric Subjects 6 to <17 Years of Age with Mild to Moderate Acute Postoperative Pain Following Elective Surgery

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2015 - June 30, 2018